PE20001034A1 - Desnaturalizantes para las sales aminas simpaticomimeticas - Google Patents
Desnaturalizantes para las sales aminas simpaticomimeticasInfo
- Publication number
- PE20001034A1 PE20001034A1 PE1999000908A PE00090899A PE20001034A1 PE 20001034 A1 PE20001034 A1 PE 20001034A1 PE 1999000908 A PE1999000908 A PE 1999000908A PE 00090899 A PE00090899 A PE 00090899A PE 20001034 A1 PE20001034 A1 PE 20001034A1
- Authority
- PE
- Peru
- Prior art keywords
- inhibitor
- compounds
- sympathomimetic amine
- water
- polymers
- Prior art date
Links
- 239000000150 Sympathomimetic Substances 0.000 title abstract 4
- 230000001975 sympathomimetic effect Effects 0.000 title abstract 4
- 239000003112 inhibitor Substances 0.000 abstract 5
- -1 TRANSITION METAL SALTS Chemical class 0.000 abstract 4
- 150000001412 amines Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000000926 separation method Methods 0.000 abstract 2
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 abstract 1
- VYIBCOSBNVFEIW-UHFFFAOYSA-N 3-phenylpropanamide Chemical compound NC(=O)CCC1=CC=CC=C1 VYIBCOSBNVFEIW-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 abstract 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 abstract 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical class [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229910017052 cobalt Inorganic materials 0.000 abstract 1
- 239000010941 cobalt Substances 0.000 abstract 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229940050410 gluconate Drugs 0.000 abstract 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000391 magnesium silicate Substances 0.000 abstract 1
- 235000012243 magnesium silicates Nutrition 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052759 nickel Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 abstract 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 abstract 1
- 239000002683 reaction inhibitor Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE a)UNA SAL ACIDA DE UNA AMINA SIMPATICOMIMETICA TAL COMO CLORHIDRATO O SULFATO DE PSEUDOEFEDRINA, CLORHIDRATO DE EFEDRINA O DE FENILPROPANILAMINA; b)UN INHIBIDOR DE COMBINACION TAL COMO SALES DE METAL DE TRANSICION (CLORURO, OXIDO, SULFATO O GLUCONATO DE HIERRO, COBALTO, COBRE, MANGANESO, NIQUEL O ZINC) Y POLIMEROS AMINO EN FORMA DE SAL NEUTRALIZADA TAL COMO COPOLIMERO DE METIL, BUTIL O DIMETILAMINOETIL METACRILATO; c)UN INHIBIDOR DE REACCION TAL COMO COMPUESTOS DE POLIHIDROXI INSOLUBLES EN AGUA, POLIHIDROXI NO POLIMEROS SOLUBLES EN AGUA, COMPUESTOS DE ESTER SOLUBLES EN ESTER; d)UN INHIBIDOR DE SEPARACION TAL COMO COMPUESTOS DE CELULOSA SOLUBLE EN AGUA, GOMAS POLISACARIDAS, POLIMEROS DE OXIDO DE POLIETILENO, POLIMEROS DE ACIDO ACRILICO, ALMIDONES, SILICATOS DE ALUMINIO Y MAGNESIO; POLIVINILPIRROLIDONAS Y ARCILLAS; SE CARACTERIZA PORQUE EL INHIBIDOR DE COMBINACION, DE REACCION E INHIBIDOR DE SEPARACION SE PRESENTAN EN CANTIDADES SUFICIENTES PARA INTERFERIR CON EL AISLAMIENTO O CON LA CONVERSION DE DICHA AMINA SIMPATICOMIMETICA EN OTROS COMPUESTOS FARMACOLOGICAMENTE ACTIVOS TAL COMO METANFETAMINA, ANFETAMINA, METCATINONA, CATINONA; SIN ALTERAR SIGNIFICATIVAMENTE LA LIBERACION DE DICHA AMINA SIMPATICOMIMETICA DE LA COMPOSICION EN COMPARACION CON LA COMPOSICION DESNATURALIZADA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9971298P | 1998-09-10 | 1998-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001034A1 true PE20001034A1 (es) | 2000-10-18 |
Family
ID=22276270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000908A PE20001034A1 (es) | 1998-09-10 | 1999-09-09 | Desnaturalizantes para las sales aminas simpaticomimeticas |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US6359011B1 (es) |
| EP (1) | EP1112089A1 (es) |
| JP (1) | JP2002524534A (es) |
| KR (1) | KR20010075021A (es) |
| CN (1) | CN1201822C (es) |
| AR (1) | AR032730A1 (es) |
| AU (2) | AU771194B2 (es) |
| BR (1) | BR9913575A (es) |
| CA (1) | CA2339354A1 (es) |
| CO (1) | CO5280050A1 (es) |
| CR (1) | CR6106A (es) |
| GT (1) | GT199900148A (es) |
| HK (1) | HK1039898A1 (es) |
| HN (1) | HN1999000156A (es) |
| MY (1) | MY117971A (es) |
| NZ (1) | NZ510012A (es) |
| PA (1) | PA8481601A1 (es) |
| PE (1) | PE20001034A1 (es) |
| SV (1) | SV1999000148A (es) |
| TW (1) | TW550071B (es) |
| UY (1) | UY25702A1 (es) |
| WO (1) | WO2000015261A1 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT199900148A (es) * | 1998-09-10 | 2001-02-28 | Desnaturalizantes para las sales aminas simpaticomimeticas. | |
| KR100863146B1 (ko) * | 2000-07-17 | 2008-10-14 | 아스텔라스세이야쿠 가부시키가이샤 | 경구 흡수 개선 의약 조성물 |
| PT2283817T (pt) * | 2000-11-30 | 2016-08-22 | Vectura Ltd | Método de fabrico de partículas para utilização numa composição farmacêutica |
| ITMI20021074A1 (it) * | 2002-05-20 | 2003-11-20 | Actimex S R L | Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102004045037A1 (de) * | 2004-09-15 | 2006-03-16 | Basf Ag | Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| ATE493118T1 (de) | 2006-01-19 | 2011-01-15 | Dow Global Technologies Inc | Biologisch wirksame zusammensetzung mit ethylcellulose |
| US9238073B2 (en) | 2006-04-12 | 2016-01-19 | Wyeth Llc | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| ES2612032T3 (es) * | 2007-06-04 | 2017-05-11 | Shear/Kershman Laboratories, Inc. | Formas farmacéuticas orales basadas en lípidos inviolables para agonistas opiáceos |
| WO2009012590A1 (en) * | 2007-07-23 | 2009-01-29 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
| RU2465916C2 (ru) * | 2007-10-19 | 2012-11-10 | Оцука Фармасьютикал Ко., Лтд. | Твердый фармацевтический препарат матричного типа |
| RU2015138422A (ru) | 2009-07-22 | 2018-12-25 | Грюненталь Гмбх | Стабильная при окислении, прочная на излом лекарственная форма |
| WO2011041414A1 (en) * | 2009-09-30 | 2011-04-07 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
| PE20141638A1 (es) | 2011-07-29 | 2014-11-22 | Gruenenthal Chemie | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
| RS56527B1 (sr) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu |
| WO2013036567A2 (en) * | 2011-09-07 | 2013-03-14 | Johnson Brent A | Methods, compositions, and compounds for the reduction of illegal methamphetamine production |
| US20150238615A1 (en) * | 2011-12-12 | 2015-08-27 | Leonard Mackles | Denaturants for sympathomimetic amines |
| US20140034885A1 (en) * | 2012-08-01 | 2014-02-06 | Acura Pharmaceuticals, Inc. | Stabilization of one-pot methamphetamine synthesis systems |
| WO2014085599A1 (en) | 2012-11-30 | 2014-06-05 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
| EP3016645A4 (en) * | 2013-07-03 | 2016-12-21 | Acura Pharmaceuticals Inc | PROCEDURE AND COMPOSITIONS FOR DETECTING FROM ABUSE |
| US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| AU2014356581C1 (en) | 2013-11-26 | 2020-05-28 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| US9642811B2 (en) | 2014-03-26 | 2017-05-09 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release biphasic matrix solid dosage form |
| US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
| AU2016319203A1 (en) * | 2015-09-10 | 2018-02-22 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| TW202002957A (zh) | 2018-02-09 | 2020-01-16 | 德商歌林達有限公司 | 包含轉化抑制劑之麻黃素及其衍生物之抗損壞調配物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3169092A (en) | 1963-09-26 | 1965-02-09 | Richardson Merrell Inc | Stabilization of amines by tartrazine and bisulfite |
| US3546142A (en) * | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
| US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
| GB1593261A (en) | 1976-07-23 | 1981-07-15 | Inveresk Res Int | Controlled release suppository |
| RO68771A2 (ro) * | 1976-08-25 | 1980-08-15 | Intreprinderea De Medicamente,Ro | Unguent antipruriginos si sicativ |
| SU1146046A1 (ru) | 1983-11-11 | 1985-03-23 | Центральный Ордена Ленина Институт Усовершенствования Врачей | Состав дл ретракции десны |
| US4493827A (en) | 1983-11-14 | 1985-01-15 | Ronald Valle | Method of inducing sleep |
| US4657757A (en) | 1985-03-29 | 1987-04-14 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
| US4601894A (en) * | 1985-03-29 | 1986-07-22 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| US4894239A (en) | 1987-06-02 | 1990-01-16 | Takeda Chemical Industries, Ltd. | Sustained-release preparation and production thereof |
| ZA904021B (en) | 1989-11-24 | 1991-02-27 | Van Der Linde Leon | Slimming preparations |
| CA2068402C (en) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| NZ267002A (en) | 1993-06-04 | 1997-07-27 | Warner Lambert Co | Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide |
| US5543405A (en) | 1993-10-22 | 1996-08-06 | Keown; Wendy J. | Composition and method for weight reduction and long term management of obesity |
| AUPM814994A0 (en) | 1994-09-14 | 1994-10-06 | Sterling Winthrop Inc. | Codeine-containing formulations |
| US5529783A (en) * | 1994-12-19 | 1996-06-25 | Mcneil-Ppc, Inc. | Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan |
| US5626878A (en) * | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| ES2202605T3 (es) | 1996-04-10 | 2004-04-01 | Warner-Lambert Company Llc | Desnaturalizantes para sales de aminas simpatomimeticas. |
| GT199900148A (es) * | 1998-09-10 | 2001-02-28 | Desnaturalizantes para las sales aminas simpaticomimeticas. |
-
1999
- 1999-09-07 GT GT199900148A patent/GT199900148A/es unknown
- 1999-09-08 US US09/391,739 patent/US6359011B1/en not_active Expired - Lifetime
- 1999-09-08 MY MYPI99003873A patent/MY117971A/en unknown
- 1999-09-09 CR CR6106A patent/CR6106A/es not_active Application Discontinuation
- 1999-09-09 PE PE1999000908A patent/PE20001034A1/es not_active Application Discontinuation
- 1999-09-09 CA CA002339354A patent/CA2339354A1/en not_active Abandoned
- 1999-09-09 JP JP2000569845A patent/JP2002524534A/ja active Pending
- 1999-09-09 HN HN1999000156A patent/HN1999000156A/es unknown
- 1999-09-09 PA PA19998481601A patent/PA8481601A1/es unknown
- 1999-09-09 SV SV1999000148A patent/SV1999000148A/es not_active Application Discontinuation
- 1999-09-09 BR BR9913575-2A patent/BR9913575A/pt not_active Application Discontinuation
- 1999-09-09 EP EP99946837A patent/EP1112089A1/en not_active Withdrawn
- 1999-09-09 NZ NZ510012A patent/NZ510012A/xx unknown
- 1999-09-09 KR KR1020017003081A patent/KR20010075021A/ko not_active Ceased
- 1999-09-09 CN CNB998107565A patent/CN1201822C/zh not_active Expired - Fee Related
- 1999-09-09 WO PCT/US1999/020708 patent/WO2000015261A1/en not_active Ceased
- 1999-09-09 HK HK02101442.0A patent/HK1039898A1/zh unknown
- 1999-09-09 UY UY25702A patent/UY25702A1/es not_active Application Discontinuation
- 1999-09-09 AR ARP990104527A patent/AR032730A1/es unknown
- 1999-09-09 AU AU59157/99A patent/AU771194B2/en not_active Ceased
- 1999-09-09 CO CO99057123A patent/CO5280050A1/es not_active Application Discontinuation
- 1999-09-10 TW TW088115613A patent/TW550071B/zh not_active IP Right Cessation
-
2001
- 2001-11-20 US US09/996,438 patent/US20020082304A1/en not_active Abandoned
-
2004
- 2004-06-18 AU AU2004202702A patent/AU2004202702B2/en not_active Ceased
-
2005
- 2005-07-20 US US11/186,681 patent/US20050256194A1/en not_active Abandoned
-
2006
- 2006-06-02 US US11/445,967 patent/US20060216268A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015261A1 (en) | 2000-03-23 |
| AU5915799A (en) | 2000-04-03 |
| CN1201822C (zh) | 2005-05-18 |
| AU2004202702A1 (en) | 2004-07-15 |
| US6359011B1 (en) | 2002-03-19 |
| US20020082304A1 (en) | 2002-06-27 |
| UY25702A1 (es) | 1999-11-17 |
| PA8481601A1 (es) | 2001-04-30 |
| BR9913575A (pt) | 2001-05-22 |
| AU771194B2 (en) | 2004-03-18 |
| US20060216268A1 (en) | 2006-09-28 |
| US20050256194A1 (en) | 2005-11-17 |
| EP1112089A1 (en) | 2001-07-04 |
| KR20010075021A (ko) | 2001-08-09 |
| CN1316911A (zh) | 2001-10-10 |
| HN1999000156A (es) | 2003-08-01 |
| CO5280050A1 (es) | 2003-05-30 |
| JP2002524534A (ja) | 2002-08-06 |
| SV1999000148A (es) | 2000-09-11 |
| NZ510012A (en) | 2002-11-26 |
| HK1039898A1 (zh) | 2002-05-17 |
| CA2339354A1 (en) | 2000-03-23 |
| MY117971A (en) | 2004-08-30 |
| GT199900148A (es) | 2001-02-28 |
| AU2004202702B2 (en) | 2007-11-22 |
| AR032730A1 (es) | 2003-11-26 |
| TW550071B (en) | 2003-09-01 |
| CR6106A (es) | 2003-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032730A1 (es) | Desnaturalizantes para las sales aminas simpaticomimeticas | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| BR0015567A (pt) | Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos | |
| UY30440A1 (es) | Nuevos compuestos | |
| WO2001060416A3 (en) | Matrix metalloproteinase inhibitors as targeting components in diagnostic agents | |
| JP2007502861A5 (es) | ||
| ECSP034850A (es) | Sal citrato de 5, 8, 14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma | |
| BR0214199A (pt) | Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração | |
| NZ594589A (en) | 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents | |
| MXPA04003192A (es) | Sales de acido succinico de 5, 7, 14-triazatetraciclo ?10.3.1.02,11.04,9? -hexadeca-2(11), 3, 5, 7, 9-pentaeno y composiciones farmacetucias de las mismas. | |
| PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
| WO2001012233A3 (en) | Sustained release formulation of a peptide | |
| NO20013674L (no) | Acetyleniske <alfa>-aminosyre-baserte sulfonamid- hydroksamsyre TACE-inhibitorer | |
| DE602004026903D1 (de) | P-glycoprotein-inhibitor, verfahren zu dessen hersiesen enthält | |
| TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
| HRP20130080T1 (hr) | Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-i i klase-iib u kombinaciji sa inhibitorima proteasoma | |
| WO2008102349A3 (en) | Terbinafine formulation for iontophoresis | |
| WO2009129305A3 (en) | Prodrugs of neuraminidase inhibitors | |
| GEP20104882B (en) | Age inhibitors | |
| ZA200307410B (en) | Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent, salts of ranelic acid and their hydrates. | |
| WO2005123049A3 (en) | A pharmaceutical composition for increasing the mitochondrial genesis | |
| WO2003059323A3 (de) | Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii | |
| AR079299A1 (es) | Mejora de los procesos para la preparacion de granulos solubles de las sales de los acidos carboxilicos que contienen piridina | |
| BR0115616A (pt) | Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1 | |
| HRP20100504T1 (hr) | 2-(4-cijanofenil)-6-hidroksilaminopirimidini koji inhibiraju hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |